Inventor · disambiguated record
Jacqueline L. Salm
Also filed as: SALM JACQUELINE · SALM JACQUELINE L
8 granted patents·5 pending applications·33 citations·filing 2019–2025
86Inventor score
Top patents by PatentIndex Score
13 records- 0196US12472163B2Compositions of matter and pharmaceutical compositionsATAI THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·22 claims
- 0295US12053453B2Compositions of matter and pharmaceutical compositionsPSILERA INC·Filed 2023·Granted Aug 6, 2024·4 cites·20 claims
- 0394US12396982B2Compositions of matter and pharmaceutical compositionsATAI THERAPEUTICS INC·Filed 2024·Granted Aug 26, 2025·2 cites·20 claims
- 0494US11759452B2Compositions of matter and pharmaceutical compositionsPSILERA INC·Filed 2021·Granted Sep 19, 2023·3 cites·19 claims
- 0594US11478449B1Compositions of matter and pharmaceutical compositionsPSILERA INC·Filed 2022·Granted Oct 25, 2022·5 cites·20 claims
- 0694US10709748B2Encapsulated cannabinoid formulations for transdermal deliveryNUTRAE LLC·Filed 2019·Granted Jul 14, 2020·11 cites·14 claims
- 0792US10709747B2Encapsulated cannabinoid formulations for oral deliveryNUTRAE LLC·Filed 2019·Granted Jul 14, 2020·6 cites·19 claims
- 0885US2025064783A1Compositions of Matter and Pharmaceutical CompositionsPSILERA INC·Filed 2024·Application pending·0 cites
- 0983US12472219B2Encapsulated cannabinoid formulations for transdermal deliveryNUTRAE LLC·Filed 2020·Granted Nov 18, 2025·1 cites·1 claims
- 1068US2020338150A1Encapsulated cannabinoid formulations for oral deliveryNUTRAE LLC·Filed 2020·Application pending·0 cites
- 1161US2025002457A1N,n-dimethyltryptamine (dmt) crystalline products and methods of making the samePSILERA INC·Filed 2022·Application pending·0 cites
- 1260US2025382266A15-ht2a receptor ligandsPSILERA INC·Filed 2023·Application pending·0 cites
- 1355US2025002478A1Modified indole compoundsPSILERA INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jacqueline L. Salm files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →